New England Research & Management, Inc. Elanco Animal Health Inc Transaction History

New England Research & Management, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$19.63 - $26.62 $14,722 - $19,965	-750 Reduced 2.76%	26,400 $518,000
Q1 2022 Apr 20, 2022	BUY	$24.65 - $29.0 $64,089 - $75,400	2,600 Added 10.59%	27,150 $708,000
Q4 2021 Jan 05, 2022	BUY	$27.74 - $34.09 $264,917 - $325,559	9,550 Added 63.67%	24,550 $697,000
Q3 2021 Oct 08, 2021	BUY	$29.2 - $36.72 $33,580 - $42,228	1,150 Added 8.3%	15,000 $478,000
Q2 2021 Jul 15, 2021	SELL	$28.76 - $35.98 $48,892 - $61,165	-1,700 Reduced 10.93%	13,850 $480,000
Q1 2021 Apr 16, 2021	SELL	$27.85 - $34.49 $15,317 - $18,969	-550 Reduced 3.42%	15,550 $458,000
Q4 2020 Jan 07, 2021	SELL	$27.53 - $33.79 $123,885 - $152,055	-4,500 Reduced 21.84%	16,100 $494,000
Q3 2020 Oct 08, 2020	SELL	$21.1 - $29.13 $244,760 - $337,908	-11,600 Reduced 36.02%	20,600 $575,000
Q2 2020 Jul 15, 2020	SELL	$18.94 - $24.93 $109,852 - $144,594	-5,800 Reduced 15.26%	32,200 $691,000
Q1 2020 Jun 15, 2020	BUY	$16.68 - $32.25 $48,372 - $93,525	2,900 Added 8.26%	38,000 $851,000
Q4 2019 Jan 14, 2020	BUY	$25.29 - $29.45 $88,515 - $103,075	3,500 Added 11.08%	35,100 $1.03 Million
Q3 2019 Nov 04, 2019	BUY	$25.62 - $34.96 $566,202 - $772,616	22,100 Added 232.63%	31,600 $840,000
Q2 2019 Jul 09, 2019	BUY	$31.11 - $34.79 $295,545 - $330,505	9,500 New	9,500 $321,000

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.42B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

Stay updated on New England Research & Management, Inc. with notifications on news.